272 related articles for article (PubMed ID: 30947275)
21. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
[TBL] [Abstract][Full Text] [Related]
22. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
23. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Qi X; Wang D; Su C; Li H; Guo X
Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835
[TBL] [Abstract][Full Text] [Related]
24. Conventional Ethiodized Oil Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma: Contemporary Single-Center Review of Clinical Outcomes.
Casadaban LC; Minocha J; Bui JT; Knuttinen MG; Ray CE; Gaba RC
AJR Am J Roentgenol; 2016 Mar; 206(3):645-54. PubMed ID: 26901023
[TBL] [Abstract][Full Text] [Related]
25. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
[TBL] [Abstract][Full Text] [Related]
26. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
[TBL] [Abstract][Full Text] [Related]
27. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
28. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
29. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.
Zhu SL; Ke Y; Peng YC; Ma L; Li H; Li LQ; Zhong JH
PLoS One; 2014; 9(12):e115834. PubMed ID: 25541684
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
31. Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases.
Izumoto H; Hiraoka A; Ishimaru Y; Murakami T; Kitahata S; Ueki H; Aibiki T; Okudaira T; Miyamoto Y; Yamago H; Iwasaki R; Tomida H; Mori K; Kishida M; Tsubouchi E; Miyata H; Ninomiya T; Kawasaki H; Hirooka M; Matsuura B; Abe M; Hiasa Y; Michitaka K; Kudo M
Oncology; 2017; 93 Suppl 1():120-126. PubMed ID: 29258105
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection.
Choi JW; Park JY; Ahn SH; Yoon KT; Ko HK; Lee DY; Lee JT; Kim KS; Choi JS; Han KH; Chon CY; Kim DY
Am J Clin Oncol; 2009 Dec; 32(6):564-9. PubMed ID: 19564783
[TBL] [Abstract][Full Text] [Related]
33. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors.
Zu QQ; Liu S; Zhou CG; Yang ZQ; Xia JG; Zhao LB; Shi HB
AJR Am J Roentgenol; 2015 Jun; 204(6):1322-8. PubMed ID: 26001244
[TBL] [Abstract][Full Text] [Related]
34. Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
Zuo CH; Xia M; Liu JS; Qiu XX; Lei X; Xu RC; Liu HC; Li JL; Li YG; Li QL; Xiao H; Hong Y; Wang XH; Zhu HZ; Wu QF; Burns M; Liu C
Asian Pac J Cancer Prev; 2015; 16(1):245-51. PubMed ID: 25640360
[TBL] [Abstract][Full Text] [Related]
35. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
[TBL] [Abstract][Full Text] [Related]
36. Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection.
Paik KY; Kim EK
Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):158-64. PubMed ID: 27020632
[TBL] [Abstract][Full Text] [Related]
37. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
[TBL] [Abstract][Full Text] [Related]
38. Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.
Op den Winkel M; Nagel D; Op den Winkel P; Trojan J; Paprottka PM; Steib CJ; Schmidt L; Göller M; Stieber P; Göhring P; Herbst A; Rentsch M; De Toni EN; Göke B; Gerbes AL; Kolligs FT
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):44-53. PubMed ID: 29076939
[TBL] [Abstract][Full Text] [Related]
39. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract][Full Text] [Related]
40. Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis.
Liang L; Xing H; Zhang H; Zhong J; Li C; Lau WY; Wu M; Shen F; Yang T
HPB (Oxford); 2018 Feb; 20(2):110-119. PubMed ID: 29174493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]